- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
9 Meters Biopharma (NASDAQ:NMTR), Quotes and News Summary
9 Meters Biopharma (NASDAQ: NMTR)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-11 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.040 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
9 Meters Biopharma Questions & Answers
You can purchase shares of 9 Meters Biopharma (NASDAQ: NMTR) through any online brokerage.
Other companies in 9 Meters Biopharma’s space includes: Opiant Pharma (NASDAQ:OPNT), Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Terns Pharma (NASDAQ:TERN) and Lipocine (NASDAQ:LPCN).
The latest price target for 9 Meters Biopharma (NASDAQ: NMTR) was reported by Truist Securities on Wednesday, June 22, 2022. The analyst firm set a price target for 2.00 expecting NMTR to rise to within 12 months (a possible 666.87% upside). 3 analyst firms have reported ratings in the last year.
The stock price for 9 Meters Biopharma (NASDAQ: NMTR) is $0.2608 last updated June 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for 9 Meters Biopharma.
9 Meters Biopharma’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for 9 Meters Biopharma.
9 Meters Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.